StockData

iHuman vs Jinxin Technology

IH and NAMI side by side, both in services-educational services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IH and NAMI compare

Jinxin Technology grew revenue faster over the last twelve months (1.6% versus −12.5% for iHuman).

iHuman keeps more of each dollar of sales as profit, with a net margin of 11.8% compared with −22.8% at Jinxin Technology.

iHuman scores higher on the StockData Score (8 against 3 for Jinxin Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIHNAMI
Size and price
Share price$1.01$1.62
Change, 1 year−62.7%−91.4%
Change, 5 years−80.0%–
Beta (5Y)0.20−0.21
Employees55810K
StockData Score
Total score8 (better)3
Valuation score00
Growth score01 (better)
Performance score3 (better)0
Health score5 (better)2
Dividend score00
Growth
Revenue growth (TTM)−12.5%1.6% (better)
Revenue growth, 5Y average8.7%–
Net income growth (TTM)−3.2% (better)−565%
EPS growth (TTM)0.00% (better)−275%
Profitability
Gross margin67.9% (better)11.0%
Operating margin8.3% (better)−25.2%
Net margin11.8% (better)−22.8%
FCF margin5.8% (better)−6.1%
Return on equity9.8% (better)−95.5%
Return on invested capital–−266%
Financial health
Debt / equity0.000.13 (better)
Interest coverage–−3257.9×
Current ratio3.57 (better)1.50
Piotroski F-score5 (better)2
Dividends and buybacks
Payout ratio41.0%–
Ownership
Held by institutions0.03%0.00%
Held by insiders32.9%59.2%
Insider net buying, 12 months–−$145K

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.